Oat Flour

DRUG5 trials

Sponsors

Hamilton Health Sciences Corporation, Massachusetts General Hospital, University of North Carolina, Chapel Hill, Stanford University, Ain Shams University

Conditions

Nut HypersensitivitiesNutritionPeanut AllergyType 1 Diabetes

Phase 1

Tolerance Following Peanut Oral Immunotherapy

CompletedNCT01750879

Massachusetts General HospitalPeanut Allergy

Start: 2013-08-31End: 2017-07-11Updated: 2021-07-28

Walnut Oral Immunotherapy for Tree Nut Allergy

WithdrawnNCT01834352

University of North Carolina, Chapel HillNut Hypersensitivities

Start: 2013-11-30End: 2013-12-31Updated: 2016-06-17

Phase 2

Peanut Allergy Oral Immunotherapy Desensitization

CompletedNCT01601522

Hamilton Health Sciences CorporationPeanut Allergy

Start: 2012-02-29End: 2021-09-30Updated: 2022-02-02

The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery

CompletedNCT02103270

Stanford UniversityPeanut Allergy

Start: 2014-04-30End: 2018-09-01Updated: 2019-09-04

Unknown Phase

Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes

CompletedNCT07593105

Ain Shams UniversityNutrition, Type 1 Diabetes

Start: 2024-10-12End: 2026-02-12Updated: 2026-05-18

Related Papers

Genetic Determinants of Peanut‐Specific <scp>IgG4</scp> Levels in the Context of Sustained Oral Peanut Exposure in the <scp>LEAP</scp> Study

Immunology2026-01-30

Baseline epitope-specific IgE profiles are predictive of sustained unresponsiveness or high threshold 1-year post oral immunotherapy in the POISED trial.

2024-11-052 citations

Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapy

Clinical Immunology2020-08-0939 citations

Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.

2020-05-1747 citations

Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.

2019-09-12237 citations

Development of a tool predicting severity of allergic reaction during peanut challenge.

2018-04-2757 citations